Seeking Alpha

Seeking Alpha Portfolio App for iPad

156 people get RGDX articles and Market Currents by email alert.

Get email alerts on RGDX »

RGDX

Response Genetics, Inc.

5/22/2013, 9:10 AM ET

Quote & Headlines Market Currents StockTalk

rgdx chart

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

156 people get RGDX articles and Market Currents by email alert.

Get email alerts on RGDX »

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual Meeting

GlobeNewswire (Mon, 7:00AM)
Response Genetics, Inc. Announces Contract With Blue Shield of California

GlobeNewswire (Thu, 7:00AM)
Emerging Biomarker Companies Redux: Positioned For Growth
Rod Raynovich • Wed, May 15 • 4 Comments
Response Genetics' CEO Discusses F1Q13 Earnings Results - Earnings Call Transcript
Tue, May 14
Response Genetics, Inc. Announces First Quarter 2013 Financial Results

GlobeNewswire (May 14, 2013)
Response Genetics to Present at the 2013 UBS Global Healthcare Conference

GlobeNewswire (May 8, 2013)
Response Genetics, Inc. to Release First Quarter 2013 Financial Results and Host Conference Call on May 14, 2013

GlobeNewswire (May 6, 2013)
Response Genetics' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 21
Response Genetics, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results

GlobeNewswire (Mar 21, 2013)
Response Genetics to Present at the 25th Annual ROTH Conference

GlobeNewswire (Mar 12, 2013)
Response Genetics, Inc. to Release Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on March 21, 2013

GlobeNewswire (Mar 7, 2013)
3 Small Cap Biotech Plays Potentially Facing Cash-Flow Issues
Matt Schilling • Mon, Feb 18 • 22 Comments
Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
Response Genetics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

PR Newswire (Nov 29, 2012)
Update On Emerging Biomarker Diagnostics: BG Medicine, Response Genetics, Vermillion
Rod Raynovich • Thu, Nov 15, 2012
Response Genetics, Inc. Announces Third Quarter Financial Results

PR Newswire (Nov 13, 2012)
Response Genetics, Inc. to Release Third Quarter Financial Results and Host Conference Call on November 13, 2012

PR Newswire (Nov 6, 2012)
Response Genetics, Inc. to Offer ROS1 Testing for Lung Cancer

PR Newswire (Nov 5, 2012)
Response Genetics Regains Compliance with NASDAQ Listing Standards

PR Newswire (Oct 8, 2012)
Response Genetics, Inc. Announces Appointment of James Wynne as Vice President, Sales & Marketing

PR Newswire (Oct 1, 2012)

To learn more about Seeking Alpha Pro, click here.

Response Genetics' Competitors: Who To Watch, Who To Worry About
Bay Area Biotech • Fri, Feb 8 • 7 Comments
Update On Emerging Biomarker Diagnostics: BG Medicine, Response Genetics, Vermillion
Rod Raynovich • Thu, Nov 15, 2012
Response Genetics: This Train Is About To Leave The Station
Microcap Growth Investor • Thu, Feb 16, 2012 • 2 Comments
Response Genetics Stock Soars 31% On $7.8M Offering News
Rod Raynovich • Fri, Feb 3, 2012
Response Genetics: An Under the Radar Company With Strong Growth
Microcap Growth Investor • Thu, May 26, 2011 • 3 Comments

Emerging Biomarker Companies Redux: Positioned For Growth
Rod Raynovich • Wed, May 15 • 4 Comments
3 Small Cap Biotech Plays Potentially Facing Cash-Flow Issues
Matt Schilling • Mon, Feb 18 • 22 Comments
Top 7 Insider Buys Filed On September 17
Markus Aarnio • Tue, Sep 18, 2012 • 4 Comments
Coming Wave Of Companion Diagnostics: Who's Making A Splash
Dave Westenberg • Thu, Jul 26, 2012 • 7 Comments
Micro Cap Medical Technology Companies
Ian Cassel • Fri, Nov 18, 2011 • 5 Comments
A Simplified ASCO 2011 List for Biotech Investor Research
Chemistfrog • Mon, May 9, 2011 • 2 Comments
Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles
Rod Raynovich • Wed, Jul 7, 2010 • 2 Comments
Three Promising Small-Cap Cancer Plays
Justin M. Hall • Mon, May 17, 2010 • 22 Comments
Response Genetics: An Earnings Primer
Andrew Nava • Wed, May 12, 2010
This Week's IPOs: Amicus Therapeutics, Jazz Pharmaceuticals, LDK Solar, Response Genetics
SA Editor Abbi Adest • Mon, May 28, 2007

Response Genetics' CEO Discusses F1Q13 Earnings Results - Earnings Call Transcript
Tue, May 14
Response Genetics' CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Mar 21
Response Genetics, Inc. Update Call Transcript
Wed, Mar 26, 2008

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual Meeting

GlobeNewswire (Mon, 7:00AM)
Response Genetics, Inc. Announces Contract With Blue Shield of California

GlobeNewswire (Thu, 7:00AM)
Response Genetics, Inc. Announces First Quarter 2013 Financial Results

GlobeNewswire (May 14, 2013)
Response Genetics to Present at the 2013 UBS Global Healthcare Conference

GlobeNewswire (May 8, 2013)
Response Genetics, Inc. to Release First Quarter 2013 Financial Results and Host Conference Call on May 14, 2013

GlobeNewswire (May 6, 2013)
Response Genetics, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results

GlobeNewswire (Mar 21, 2013)
Response Genetics to Present at the 25th Annual ROTH Conference

GlobeNewswire (Mar 12, 2013)
Response Genetics, Inc. to Release Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on March 21, 2013

GlobeNewswire (Mar 7, 2013)
Response Genetics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

PR Newswire (Nov 29, 2012)
Response Genetics, Inc. Announces Third Quarter Financial Results

PR Newswire (Nov 13, 2012)
Response Genetics, Inc. to Release Third Quarter Financial Results and Host Conference Call on November 13, 2012

PR Newswire (Nov 6, 2012)
Response Genetics, Inc. to Offer ROS1 Testing for Lung Cancer

PR Newswire (Nov 5, 2012)
Response Genetics Regains Compliance with NASDAQ Listing Standards

PR Newswire (Oct 8, 2012)
Response Genetics, Inc. Announces Appointment of James Wynne as Vice President, Sales & Marketing

PR Newswire (Oct 1, 2012)
London Markets: Vodafone buoys U.K. stocks; BAE and Next sink

at MarketWatch.com (Sep 13, 2012)
Response Genetics Raises $8.8 Million in Financing

PR Newswire (Sep 13, 2012)
Response Genetics, Inc. Announces Second Quarter Financial Results

PR Newswire (Aug 14, 2012)
Response Genetics, Inc. to Release Second Quarter Financial Results and Host Conference Call on August 14, 2012

PR Newswire (Aug 7, 2012)
Response Genetics, Inc. to Offer Enhanced ALK Testing Program for Metastatic Lung Cancer Patients

Business Wire (Jun 28, 2012)
Response Genetics Announces Presentation of Lung Cancer Study Results at 2012 American Society of Clinical Oncology Annual Meeting

Business Wire (May 30, 2012)

RGDX vs. ETF Alternatives

Company Description

Currently, there's no company description for RGDX.

Sector: Healthcare

Industry: Medical Laboratories & Research

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 16, 9:14 AM Premarket gainers: RGDX +24%. EGLE +23%. EFUT +19%. TSLA +13%. CSCO +13%. SCTY +11%. DQ +9%. HALO +8%. DANG +7%. AV +7%. YRCW +8%. NBG +7%. KSS +7%. SPWR +6%.
Losers: NCT -53%. SNFCA -24%. AMD -10%. NQ -7%. CYCC -5%. Comment! [On the Move]
Thursday, May 16, 7:42 AM Response Genetics (RGDX) jumps 29.63% premarket after announcing an agreement to join all of Blue Shield of California's provider networks. This is the company's first Blue Cross Blue Shield contract. (PR) Comment! [On the Move, Healthcare]
Tuesday, May 14, 9:15 AM Response Genetics (RGDX): Q1 EPS of -$0.03 beats by $0.01. Revenue of $5.6M (+40% Y/Y) beats by $0.7M. (PR) Comment! [Earnings, Healthcare]
Thursday, March 21, 7:08 AM Response Genetics (RGDX): Q4 EPS of -$0.01 beats by $0.05. Revenue of $5.5M (+11% Y/Y) beats by $0.34M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, March 18, 12:48 PM Midday top 10 gainers: YRCW +25%. PRWT +22%. ULTR +17%. IG +17%. CHYR +16%. ATOS +14%. TA +13%. NYMX +13%. WILC +11%. SORL +11%.
Midday top 10 losers: AMBO -19%. PTX -12%. SOL -10%. CNET -10%. EMITF -9%. TSEM -8%. MNDO -8%. RGDX -8%. JVA -8%. AMBA -8%. 1 Comment [On the Move]
Tuesday, November 27, 2012, 12:45 PM Midday top 10 gainers: ACAD +141%. CPSL +30%. IMMR +30%. RAH +27%. TSPT +12%. BWEN +12%. CUR +12%. FOLD +10%. FONR +10%. CDTI +10%. Midday top 10 Losers: STV -11%. MMR -9%. THO -11%. RECV -10%. CBAK -9%. BLIN -12%. ENMD -8%. RGDX -8%. ARCI -8%. BV -8%. Comment!
Tuesday, November 13, 2012, 6:34 AM Response Genetics (RGDX): Q3 EPS of -$0.07 in-line. Revenue of $5.4M beats by $0.9M. (PR) Comment! [Earnings, Healthcare]
Thursday, September 13, 2012, 3:10 PM Response Genetics (RGDX +33.3%) ramps higher today after it announced earlier that it entered into a purchase agreement with GlaxoSmithKline (GSK +1.7%) and one of its existing significant stockholders to raise $8.8M from the private placement of 8M newly issued shares at $1.10 per share. Comment! [Healthcare, On the Move]